Who Owns CellaVision Company?

CellaVision Bundle

Get Full Bundle:

	BCG	$15	$10
	5 FORCES	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns CellaVision?

Understanding CellaVision's ownership is key to grasping its strategic path and accountability. Founded in Lund, Sweden, in 1994, the company initially focused on digitizing manual blood cell analysis.

Since its Nasdaq Stockholm listing in 2018, CellaVision has transformed into a global leader in digital microscopy, offering advanced solutions for analyzing blood and other body fluid cells. Their systems improve laboratory efficiency and diagnostic accuracy.

As of July 25, 2025, CellaVision holds a market capitalization of $450 million, with 23.9 million shares outstanding. In 2024, the company achieved sales of SEK 723 million and aims for 15% annual growth over an economic cycle. The company's product portfolio includes solutions like the CellaVision BCG Matrix.

CellaVision's origins trace back to 1994 in Lund, Sweden, with entrepreneur Christer Fåhraeus as the founder. Fåhraeus, possessing a background in medicine, bioengineering, and mathematics, envisioned a technological leap from traditional microscopes in disease diagnostics. While precise initial equity details remain undisclosed, Fåhraeus is recognized as the driving force behind the company's inception.

Founder's Vision

Christer Fåhraeus founded CellaVision with the goal of modernizing diagnostic methods in healthcare.

Early Challenges

The company's initial phase was marked by significant financial constraints and numerous setbacks.

Key Early Contributors

Yvonne Mårtensson was instrumental in the company's growth, while Lars Gatenbeck provided essential early funding.

Founding Team's Role

These individuals were crucial in navigating the company's formative years and realizing the founder's vision.

Undisclosed Early Investment

Details regarding early angel investors or friends and family investments are not publicly available.

Founding Ownership Structure

Specifics on initial shareholding percentages and founder equity splits are not detailed in public records.

The early trajectory of CellaVision was defined by perseverance through what is described as 'decades of hard work, failures, and a constant shortage of funds'. Yvonne Mårtensson played a pivotal role in the company's development, and Lars Gatenbeck provided critical financial support during periods of scarcity. These contributions were vital in shaping the company's initial growth and reflecting the founding team's commitment. Information concerning early backers, angel investors, or private funding rounds, as well as details on vesting schedules, shareholder agreements, or any initial ownership disputes, is not readily accessible through available public information. Understanding the Competitors Landscape of CellaVision can provide context to the challenges and opportunities faced during its early stages.

Founders and Early Ownership Insights

The establishment of CellaVision was primarily driven by Christer Fåhraeus, with significant operational and financial contributions from Yvonne Mårtensson and Lars Gatenbeck, respectively.

• Founder: Christer Fåhraeus
• Key operational figure: Yvonne Mårtensson
• Key financial backer: Lars Gatenbeck
• Company founded: 1994 in Lund, Sweden
• Early company phase characterized by financial challenges and hard work.

CellaVision SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

CellaVision's ownership structure saw a significant shift with its public listing on NASDAQ Stockholm, Mid Cap, in 2018. This move opened the company to a broader range of investors, influencing its shareholding pattern over time.

As of December 31, 2024, CellaVision was held by 6,862 shareholders, with a notable portion, 39%, being foreign-owned, and 29% held by Swedish institutional investors. The total number of shares and votes stood at 23,851,547 as of April 2, 2025. The company's CellaVision ownership is characterized by a diverse group of institutional investors, alongside a significant stake retained by its founder, Christer Fåhraeus. This distribution suggests a stable ownership base with continued founder influence, reflecting a commitment to the company's long-term vision. The company's Marketing Strategy of CellaVision likely benefits from this stable shareholder foundation.

Key CellaVision Ownership Insights

Understanding who owns CellaVision provides insight into its governance and strategic direction. The company's shareholding pattern highlights a blend of institutional and founder ownership.

• William Demant Fonden is the largest shareholder, holding 19.93% of capital and votes as of June 2025.
• Founder Christer Fåhraeus maintains a substantial stake of 6.83%.
• Swedish and foreign institutional investors collectively represent a significant portion of the CellaVision stock ownership.
• The company has not held any treasury shares, indicating all issued shares are outstanding.

CellaVision PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The governance of CellaVision is overseen by its Board of Directors, with shareholder influence playing a key role in nominations. The company adheres to Swedish corporate governance standards, ensuring a structured approach to decision-making and oversight.

Voting power within CellaVision is distributed based on share ownership, with each share granting one vote. As of December 31, 2024, significant voting power was held by William Demant Invest A/S and Grenlunden CEVI AB, both possessing at least 10 percent of the votes and capital. Christer Fåhraeus, a founder and board member, held 6.83% of the shares as of June 26, 2025, indicating a substantial individual stake. The company operates under a one-share-one-vote principle, with no evidence of preferential share classes that would alter this fundamental voting structure.

Understanding CellaVision's Shareholding

CellaVision's ownership structure is characterized by a clear distribution of voting rights among its shareholders. Major investors play a direct role in the company's governance through their influence on board nominations.

• Each share carries one vote, ensuring equal voting rights per share.
• William Demant Invest A/S and Grenlunden CEVI AB are significant shareholders, each holding over 10% of votes and capital as of December 31, 2024.
• Christer Fåhraeus maintains a notable voting power with 6.83% of shares as of June 26, 2025.
• The company's structure does not feature dual-class shares or other mechanisms that grant disproportionate control.
• Understanding CellaVision's ownership is key to grasping its strategic direction and Revenue Streams & Business Model of CellaVision.

CellaVision Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Recent developments show a dynamic ownership landscape for CellaVision, with significant institutional backing and a founder retaining a notable stake. The company's financial performance, marked by strong sales growth and improved margins, has also influenced investor sentiment and ownership trends over the past few years.

CellaVision's ownership structure as of December 31, 2024, indicates a substantial presence of institutional investors, with foreign entities holding 39% of the shares and Swedish institutions owning 29%. This reflects a broad investor base and confidence in the company's trajectory. While founder Christer Fåhraeus continues to be a significant shareholder, recent insider transactions show sales by Fåhraeus in June 2025 and August 2024, suggesting potential adjustments in his personal holdings. The company's growth target of 15% per year over an economic cycle, coupled with a robust financial position including the repayment of most bank loans, positions it favorably for future developments and potential shifts in its shareholding pattern.

Institutional Investor Dominance

Foreign and Swedish institutional investors collectively held 68% of CellaVision's shares as of December 31, 2024. This strong institutional ownership underscores confidence in the company's strategic direction and financial health.

Founder's Stake and Transactions

Founder Christer Fåhraeus maintains a significant stake, though recent sales in June 2025 and August 2024 indicate personal portfolio adjustments. Understanding these transactions is key to tracking CellaVision founder ownership.

Financial Performance Impact on Ownership

The company's strong financial results, including a 25.16% stock surge after Q1 2025 earnings, suggest that positive performance attracts and retains investors. This financial reporting is crucial for CellaVision investor relations.

Growth and Financial Stability

CellaVision's commitment to a 15% annual growth target and its repayment of bank loans contribute to its financial stability. This stability is a key factor for CellaVision's current ownership status and future investment appeal.

CellaVision Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔